Encapsulation of eucalyptus essential oil in chitosan nanoparticles and its effect on MDA-MB-231 cells

Document Type : Research Paper


1 Department of Biotechnology, Iranian Research Organization for Science and Technology (IROST), Tehran, Iran

2 Nanobiotechnology Department, Faculty of Innovative Science and Technology, Razi University, Kermanshah, Iran

3 Department of Chemical Technologies, Iranian Research Organization for Science and Technology (IROST), Tehran, Iran

4 Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran



Objective(s): Encapsulation of essential oil in polymeric nanoparticles (NPs) increases their retention and improves their efficacy. Here, eucalyptus essential oil (EEO) encapsulate in the chitosan (CS) NPs increases its retention, and enhances the anticancer effect of EEO.
Materials and Methods: The effects of pH, chitosan sodium tripolyphosphate ratio, and chitosan concentration on the size and charge NPs were evaluated. The success of EEO encapsulation was confirmed by FT-IR, UV–Vis spectroscopy, and GC techniques. The toxic effect of free EEO and CS-EEO NPs was investigated in MDA-MB-231 breast cancer cells and fibroblast normal cells. 
Results: The optimized obtained EEO -loaded chitosan nanoparticles (CS-EEO NPs) were spherical with an average diameter of 86 nm, a polydispersity index below 0.4, and positive zeta potential (+14.25 mV) as confirmed. Increasing the concentration and pH of the chitosan solution and decreasing the chitosan/sodium tripolyphosphate ratio, the size of NPs decreased. Loading capacity (LC) and encapsulation efficiency (EE) of EEO in the NPs were about 45% and 32–76%, respectively. The chitosan nanoparticles exhibited a biphasic release profile with the release of 87% of the EEO in the first 5 h, followed by a sustained release for the next 43 h. 
Conclusion: The free EEO was more toxic for MDA-MB-231 cells than fibroblast cells; however, CS-EEO NPs were non-toxic for fibroblast cells and more toxic for MDA-MB-231 cells compared to free EEO. Therefore, the CS-EEO NPs illustrate smart behavior in killing cancerous cells and will be suggested for breast cancer drug delivery.


1.    Mohapatra A, Sathiyamoorthy P, Park IK. Metallic nanoparticle-mediated immune cell regulation and advanced cancer immunotherapy. Pharmaceutics. 2021;13(11):1867.
2.    Chen J, Cong X. Surface-engineered nanoparticles in cancer immune response and immunotherapy: Current status and future prospects. Biomed Pharmacother. 2023;157:113998.
3.    Kumari M, Sharma N, Manchanda R, Gupta N, Syed A, Bahkali AH, et al. PGMD/curcumin nanoparticles for the treatment of breast cancer. Sci Rep. 2021;11(1):1-17.
4.    Bhalla Y, Gupta VK, Jaitak V. Anticancer activity of essential oils: a review. J Sci Food Agric. 2013;93(15):3643-53.
5.    Abiri R, Atabaki N, Sanusi R, Malik S, Abiri R, Safa P, et al. New insights into the biological properties of eucalyptus-derived essential oil: A promising green anti-cancer drug. Food Rev Int. 2021:1-36.
6.    Garcia LGS, da Rocha MG, Lima LR, Cunha AP, de Oliveira JS, de Andrade ARC, et al. Essential oils encapsulated in chitosan microparticles against Candida albicans biofilms. Int J Biol Macromol. 2021;166:621-32.
7.    Homayonpour P, Jalali H, Shariatifar N, Amanlou M. Effects of nano-chitosan coatings incorporating with free/nano-encapsulated cumin (Cuminum cyminum L.) essential oil on quality characteristics of sardine fillet. Int J Food Microbiol. 2021;341:109047.
8.    Alhodieb FS, Barkat MA, Barkat HA, Ab Hadi H, Khan MI, Ashfaq F, et al. Chitosan-modified nanocarriers as carriers for anticancer drug delivery: Promises and hurdles. Int J Biol. Macromol. 2022.
9.    Huang M, Xu Y, Xu L, Bai Y, Xu X. Interactions of water-soluble myofibrillar protein with chitosan: Phase behavior, microstructure and rheological properties. IFSET. 2022;78:103013.
10.    Hasan S, Boddu VM, Viswanath DS, Ghosh TK. Preparation and Application of Chitosan Derivatives.  Chitin and Chitosan: Springer; 2022. p. 103-55.
11.    Ahmed MM, Anwer MK, Fatima F, Aldawsari MF, Alalaiwe A, Alali AS, et al. Boosting the anticancer activity of sunitinib malate in breast cancer through lipid polymer hybrid nanoparticles approach. Polymers. 2022;14(12):2459.
12.    Zhou Z, Yang Y, He L, Wang J, Xiong J. Molecular docking reveals Chitosan nanoparticle protection mechanism for dentin against Collagen-binding bacteria. J Mater Sci Mater Med. 2022;33(5):1-9.
13.    Obeidat WM, Gharaibeh SF, Jaradat A. The Influence of Drugs Solubilities and Chitosan-TPP Formulation Parameters on the Mean Hydrodynamic Diameters and Drugs Entrapment Efficiencies into Chitosan-TPP Nanoparticles. AAPS PharmSciTech. 2022;23(7):1-16.
14.    Athavale R, Sapre N, Rale V, Tongaonkar S, Manna G, Kulkarni A, et al. Tuning the surface charge properties of chitosan nanoparticles. Mater. 2022;308:131114.
15.    Yuan Y, Gao J, Zhai Y, Li D, Fu C, Huang Y. Mixing efficiency affects the morphology and compactness of chitosan/tripolyphosphate nanoparticles. Carbohydr Polym. 2022;287:119331.
16.    Hosseini SF, Zandi M, Rezaei M, Farahmandghavi F. Two-step method for encapsulation of oregano essential oil in chitosan nanoparticles: preparation, characterization and in vitro release study. Carbohydr Polym. 2013;95(1):50-56.
17.    Zielińska A, Ferreira NR, Feliczak-Guzik A, Nowak I, Souto EB. Loading, release profile and accelerated stability assessment of monoterpenes-loaded solid lipid nanoparticles (SLN). Pharm Dev Technol. 2020;25(7):832-844.
18.    Maghsoodlou MT, Kazemipoor N, Valizadeh J, Seifi MFN, Rahneshan N. Essential oil composition of Eucalyptus microtheca and Eucalyptus viminalis. Avicenna J Phytomed.
19.    Zeinabad HA, Zarrabian A, Saboury AA, Alizadeh AM, Falahati M. Interaction of single and multi wall carbon nanotubes with the biological systems: tau protein and PC12 cells as targets. Sci Rep. 2016;6(1):1-23.